All Stories

  1. Enhancing result reliability by addressing potential confounding factors

    Article • Microbiology Spectrum, February 2025, ASM Journals

    Dr Satoru Mitsuboshi

  2. Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

    Article • European Journal of Clinical Pharmacology, November 2024, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  3. Association between mineralocorticoid receptor antagonists and kidney harm: A systematic review and meta‐analysis of randomized controlled trials

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2024, Wiley

    Dr Satoru Mitsuboshi

  4. Association between gastroprotective agents and acute kidney injury in patients receiving non‐steroidal anti‐inflammatory drugs: Analysis of a Japanese hospital‐based database

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2024, Wiley

    Dr Satoru Mitsuboshi

  5. Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database

    Article • Journal of Infection, August 2024, Elsevier

    Dr Satoru Mitsuboshi

  6. Individual dipeptidyl peptidase‐4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta‐analysis

    Article • Basic & Clinical Pharmacology & Toxicology, May 2024, Wiley

    Dr Satoru Mitsuboshi

  7. Association between use of romosozumab and cardiovascular events: analysis of the Japanese Adverse Event Report database

    Article • January 2024, Authorea, Inc.

    Dr Satoru Mitsuboshi

  8. Influence of vasopressin receptor antagonists on triple‐whammy acute kidney injury: A VigiBase analysis

    Article • British Journal of Clinical Pharmacology, December 2023, Wiley

    Dr Satoru Mitsuboshi

  9. Effect of cytochrome P450 1A2 inhibitors on rhabdomyolysis in patients on clozapine: Analysis using the US Food and Drug Administration's Adverse Event Reporting System

    Article • Schizophrenia Research, December 2023, Elsevier

    Dr Satoru Mitsuboshi

  10. Comparison of different sustained‐release opioids and acute respiratory conditions in patients with cancer and chronic kidney disease

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, November 2023, Wiley

    Dr Satoru Mitsuboshi

  11. Reply to: Comments on Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics

    Article • International Journal of Cancer, October 2023, Wiley

    Dr Satoru Mitsuboshi

  12. Urate‐Lowering Drugs And Muscle Injury: A Systematic Review and Network Meta‐Analysis

    Article • The Journal of Clinical Pharmacology, October 2023, Wiley

    Dr Satoru Mitsuboshi

  13. Reply to: Comment: Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System

    Article • The Journal of Clinical Pharmacology, August 2023, Wiley

    Dr Satoru Mitsuboshi

  14. Association between misoprostol and non‐steroidal anti‐inflammatory drug‐induced kidney injury: a systematic review and meta‐analysis

    Article • British Journal of Clinical Pharmacology, June 2023, Wiley

    Dr Satoru Mitsuboshi

  15. Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics

    Article • International Journal of Cancer, June 2023, Wiley

    Dr Satoru Mitsuboshi

  16. Detection of Vaccine Adverse Events Before Package Insert Revisions Using a Japanese Spontaneous Reporting System

    Article • The Journal of Clinical Pharmacology, May 2023, Wiley

    Dr Satoru Mitsuboshi

  17. Proton Pump Inhibitors and Rhabdomyolysis: Analysis of Two Different Cross-Sectional Databases

    Article • Annals of Pharmacotherapy, February 2023, SAGE Publications

    Dr Satoru Mitsuboshi

  18. Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor

    Article • European Journal of Cancer, February 2023, Elsevier

    Dr Satoru Mitsuboshi

  19. Association between use of febuxostat and muscle injury: A disproportionality analysis and meta‐analysis of randomized controlled trials

    Article • British Journal of Clinical Pharmacology, January 2023, Wiley

    Dr Satoru Mitsuboshi

  20. Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database

    Article • Journal of Pharmacy Technology, December 2022, SAGE Publications

    Dr Satoru Mitsuboshi

  21. Characterization of Immune Checkpoint Inhibitor–Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System

    Article • The Journal of Clinical Pharmacology, December 2022, Wiley

    Dr Satoru Mitsuboshi

  22. Evaluation of Preoperative Risk Factors for Sugammadex‐Induced Anaphylaxis: Analysis of the Japanese Adverse Drug Event Report Database

    Article • The Journal of Clinical Pharmacology, July 2022, Wiley

    Dr Satoru Mitsuboshi

  23. Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta‐analysis

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, June 2022, Wiley

    Dr Satoru Mitsuboshi

  24. Association Between Antiosteoporotic Drugs and Risk of Acute Kidney Injury: A Cross‐Sectional Study Using Disproportional Analysis and a Pharmacovigilance Database

    Article • The Journal of Clinical Pharmacology, June 2022, Wiley

    Dr Satoru Mitsuboshi

  25. Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database

    Article • Basic & Clinical Pharmacology & Toxicology, February 2022, Wiley

    Dr Satoru Mitsuboshi

  26. Risk of Pregabalin‐Induced Hypoglycemia: Analysis of the Japanese Adverse Drug Event Report Database

    Article • The Journal of Clinical Pharmacology, January 2022, Wiley

    Dr Satoru Mitsuboshi

  27. Risk of kidney injury in patients on concomitant oral vancomycin and piperacillin‐tazobactam: Analysis of the pharmacovigilance database in Japan

    Article • Basic & Clinical Pharmacology & Toxicology, November 2021, Wiley

    Dr Satoru Mitsuboshi

  28. Risk of Hematologic Events With Coadministration of Methotrexate and the Breast Cancer Resistance Protein Inhibitor Febuxostat

    Article • Annals of Pharmacotherapy, November 2021, SAGE Publications

    Dr Satoru Mitsuboshi

  29. Inappropriate use of ozone generators and their sales status: questionnaire survey of healthcare providers and investigation of online sales

    Article • Journal of Hospital Infection, November 2021, Elsevier

    Dr Satoru Mitsuboshi

  30. Fluoropyridmidine use and hypertriglyceridemia among Japanese patients: analysis of adverse event database

    Article • International Journal of Clinical Pharmacy, September 2021, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  31. Risk of muscle toxicity events for daptomycin with and without statins: Analysis of the Japanese Adverse Event Report database

    Article • Basic & Clinical Pharmacology & Toxicology, June 2021, Wiley

    Dr Satoru Mitsuboshi

  32. Amantadine and Fatal Events in Patients With Chronic Kidney Disease: Analysis of the Japanese Adverse Event Report Database

    Article • Annals of Pharmacotherapy, June 2021, SAGE Publications

    Dr Satoru Mitsuboshi

  33. Association Between Baclofen and Respiratory Depression in Patients With Chronic Kidney Disease

    Article • The Journal of Clinical Pharmacology, March 2021, Wiley

    Dr Satoru Mitsuboshi

  34. Association between extended-spectrum β-lactamase–producing Escherichia coli and oral third-generation cephalosporins

    Article • Infection Control, January 2021, Cambridge University Press

    Dr Satoru Mitsuboshi

  35. Differences in risk factors for anticoagulant‐related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report database

    Article • British Journal of Clinical Pharmacology, December 2020, Wiley

    Dr Satoru Mitsuboshi

  36. ARN risk of warfarin and DOACs

    Article • British Journal of Clinical Pharmacology, November 2020, Wiley

    Dr Satoru Mitsuboshi

  37. Regional outbreak of methicillin-resistant Staphylococcus aureus ST2725-t1784 in rural Japan

    Article • Infection Control, November 2020, Cambridge University Press

    Dr Satoru Mitsuboshi

  38. Concomitant Use of Acetaminophen and Aspirin Increases Risk of Kidney Injury: Analysis of the Japanese Adverse Drug Event Report Database

    Article • The Journal of Clinical Pharmacology, October 2020, Wiley

    Dr Satoru Mitsuboshi

  39. Inappropriate sales of hypochlorous acid solution in Japan: An online investigation

    Article • Infection Control, October 2020, Cambridge University Press

    Dr Satoru Mitsuboshi

  40. Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan

    Article • Journal of Oncology Pharmacy Practice, May 2020, SAGE Publications

    Dr Satoru Mitsuboshi

  41. Does Quick Sepsis-Related Organ Failure Assessment Suggest the Use of Initial Empirical Carbapenem Therapy in Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Bacteria? :A Multicenter Case-Control Study

    Article • Japanese Journal of Infectious Diseases, March 2019, Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis

    Dr Satoru Mitsuboshi

  42. Impact of alcohol-based hand sanitizers, antibiotic consumption, and other measures on detection rates of antibiotic-resistant bacteria in rural Japanese hospitals

    Article • Journal of Infection and Chemotherapy, September 2018, Elsevier

    Dr Satoru Mitsuboshi

  43. Antimicrobial Therapeutic Drug Monitoring Performance Rate in Niigata: Evaluation between Performance Rate and Relevant Factors

    Article • Japanese Journal of Infection Prevention and Control, March 2018, Japanese Society of Environmental Infections

    Dr Satoru Mitsuboshi

  44. Clinical advantage and tolerability of ibandronate in hemodialysis patients: a retrospective study

    Article • Renal Replacement Therapy, January 2018, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  45. Low Continuity Rate of Sucroferric Oxyhydroxide among Japanese Hemodialysis Patients with High Phosphate Binder Pill Burden

    Article • YAKUGAKU ZASSHI, January 2018, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  46. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report

    Article • Journal of Oncology Pharmacy Practice, July 2017, SAGE Publications

    Dr Satoru Mitsuboshi

  47. Clinical Advantage of Topiroxostat

    Article • Biological and Pharmaceutical Bulletin, January 2017, Pharmaceutical Society of Japan

    Dr Satoru Mitsuboshi

  48. Evaluation of Combination Effect of an Alcohol-based Hand Rub: Introducing Portable Bottles and Providing the Feedback

    Article • Japanese Journal of Infection Prevention and Control, January 2017, Japanese Society of Environmental Infections

    Dr Satoru Mitsuboshi

  49. No effect of protein binding ratio of levofloxacin in hemodialysis patients

    Article • Renal Replacement Therapy, July 2016, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  50. Risk Factor of Isolation Rate of MRSA: Evaluation of 5 Hospitals in Niigata

    Article • Japanese Journal of Infection Prevention and Control, January 2016, Japanese Society of Environmental Infections

    Dr Satoru Mitsuboshi

  51. Switching from allopurinol to febuxostat: efficacy and tolerability in hemodialysis patients.

    Article • Journal of Pharmaceutical Health Care and Sciences, October 2015, Springer Science + Business Media

    Dr Satoru Mitsuboshi

  52. Studies on the effects of brown rice diet on lipid metabolism in cholesterolemia

    Article • Journal for the Integrated Study of Dietary Habits, January 2014, Japanese Association for the Integrated Study of Dietary Habits

    Dr Satoru Mitsuboshi